Table 1:
Basic Demographics of Esophageal Adenocarcinoma Cases, 1975–2015 (N=34,443)
| <50 | 50–69 | ≥70 | Total | ||
|---|---|---|---|---|---|
| Gender | Male | 2,442 (88.3%) | 15,750 (89.2%) | 11,503 (82.0%) | 29,695 (86.2%) |
| Female | 323 (11.7%) | 1,900 (10.8%) | 2,525 (18.0%) | 4,748 (13.8%) | |
| Race | White | 2,578 (93.2%) | 16,699 (94.6%) | 13,468 (96.0%) | 32,745 (95.1%) |
| Black | 84 (3.0%) | 532 (3.0%) | 247 (1.8%) | 863 (2.5%) | |
| Other/Unknown | 103 (3.7%) | 419 (2.4%) | 313 (2.2%) | 835 (2.3%) | |
| Stage | Localized | 460 (16.6%) | 4,047 (22.9%) | 4,590 (3.3%) | 9,098 (26.4%) |
| Regional/Distant | 2,305 (83.4%) | 13,603 (77.1%) | 9,438 (67.2%) | 25,345 (73.6%) | |
| Year of Diagnosis | 1975–1989 | 168 (10.4%) | 895 (55.4%) | 551 (34.2%) | 1,614 (4.7%) |
| 1990–1999 | 371 (9.1%) | 1,986 (48.8%) | 1,715 (42.1%) | 4,072 (11.8%) | |
| 2000–2015 | 2,226 (7.7%) | 14,769 (51.4%) | 11,762 (40.9%) | 28,757 (83.5%) | |
| Receipt of Chemotherapy* | 1,331 (74.0%) | 8,634 (67.4%) | 5,056 (47.0%) | 15,021 (59.2%) | |
| Receipt of Radiation Therapy* | 963 (53.5%) | 6,948 (54.2%) | 4,974 (46.3%) | 12,885 (50.8%) | |
| Receipt of Surgical or Endoscopic Therapy* | 607 (33.7%) | 4,742 (37.0%) | 2,448 (22.8%) | 7,797 (30.7%) | |
| Total | 2,765 (8.0%) | 17,650 (51.2%) | 14,028 (40.8%) | 34,442 | |
*
Data presented only for patients diagnosed from 2004–2015